[1]
Ntertsos, N. et al. 2023. Clinical Approach to Immunotherapy-induced Type 1 Diabetes Mellitus: A Case of Pembrolizumab Associated Insulin-dependent Diabetes in a Patient with NSCLC. Journal of Pulmonology and Respiratory Research. 7, 2 (Sep. 2023), 024–027. DOI:https://doi.org/10.29328/journal.jprr.1001047.